Search results
Showing 1651 to 1665 of 1809 results for nice guidelines
Cannabidiol with clobazam for treating seizures associated with Dravet syndrome (TA614)
Evidence-based recommendations on cannabidiol (Epidyolex) with clobazam for seizures associated with Dravet syndrome in people aged 2 years and older.
NICE has developed a medtech innovation briefing (MIB) on the Epidrum for aiding access to the epidural space
CG160/1 | Symptoms and signs of serious illness: - NICE recommends a UK-based epidemiological study on the symptoms and signs of
Details, meeting dates and minutes of the independent technology appraisal committees
Breast reconstruction using lipomodelling after breast cancer treatment (IPG417)
Evidence-based recommendations on breast reconstruction using lipomodelling after breast cancer treatment. This involves taking fat from the abdomen or thighs and injecting it into the breast in the area of the deformity caused by surgery.
View recommendations for IPG417Show all sections
Sections for IPG417
Evidence-based recommendations on on regorafenib (Stivarga) for previously treated gastrointestinal stromal tumours in adults.
Entrectinib for treating NTRK fusion-positive solid tumours (TA644)
Evidence-based recommendations on entrectinib (Rozlytrek) for treating neurotrophic tyrosine receptor kinase (NTRK) fusion-positive solid tumours in adults and children over 12 years.
Discontinued [GID-TAG402]
Belzutifan for treating tumours associated with von Hippel-Lindau disease (TA1011)
Evidence-based recommendations on belzutifan (Welireg) for treating tumours associated with von Hippel-Lindau disease in adults.
Any explanatory notes(if applicable) Why this is importantThe guideline committee noted that there were 2 possible approaches to using...
What training, support or interventions help to reduce caring-related accidents or incidents?
are included in the psychological and emotional support section of this guideline.By consensus, the committee also agreed to add some...
cancer. But you do not have to take it: there are pros and cons. The medicine NICE recommends for most women who have been through the...
Ravulizumab for treating atypical haemolytic uraemic syndrome (TA710)
Evidence-based recommendations on ravulizumab (Ultomiris) for treating atypical haemolytic uraemic syndrome in people weighing 10 kg or more.
NICE has developed a medtech innovation briefing (MIB) on plasma EGFR mutation tests for adults with locally advanced or metastatic non-small-cell lung cancer .
Evidence-based recommendations on bortezomib (Velcade) for treating multiple myeloma before chemotherapy and stem cell transplant in adults.